GGrantIndex
Sort

130,381 grants matching hiv

Systems Biology of Immune Reconstitution in HIV / AIDS

$840,263
Dana H. Gabuzda · Dana-Farber Cancer Inst · DP1 · FY2014 · DA

Systems Biology of Immune Reconstitution in HIV / AIDS

$840,263
Dana H. Gabuzda · Dana-Farber Cancer Inst · DP1 · FY2013 · DA

Systems Biology of Immune Reconstitution in HIV / AIDS

$840,263
Dana H. Gabuzda · Dana-Farber Cancer Inst · DP1 · FY2011 · DA

IN VIVO INDUCTION OF HIV SPECIFIC CTL BY DENDRITIC CELLS

$840,253
New York University School Of Medicine · R01 · FY2003 · AI

Aging and Fracture Risk among HIV-infected and HIV-uninfected Men

$840,190
Todd T Brown · Johns Hopkins University · R01 · FY2011 · AI

Determining the effects of broadly neutralizing antibodies at antiretroviral therapy initiation

$840,170
Katharine June Bar · University Of Pennsylvania · R01 · FY2025 · AI

Understanding HIV-1 persistence in cytotoxic CD4+ T lymphocytes at the single cell level

$840,074
Ya-Chi Ho · Yale University · R01 · FY2024 · AI

Understanding HIV-1 persistence in cytotoxic CD4+ T lymphocytes at the single cell level

$840,074
Ya-Chi Ho · Yale University · R01 · FY2025 · AI

Development of DSB, a novel potent HIV inhibitor

$840,027
Panacos Pharmaceuticals, Inc. · R44 · FY2004 · AI

Enabling the study of endogenous proteins in live cells

$840,000
Alice Y Ting · Massachusetts Institute Of Technology · DP1 · FY2008 · OD

Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection

$839,997
Harris Goldstein · Albert Einstein College Of Medicine · R01 · FY2024 · AI

Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection

$839,997
Harris Goldstein · Albert Einstein College Of Medicine · R01 · FY2022 · AI

Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection

$839,997
Harris Goldstein · Albert Einstein College Of Medicine · R01 · FY2023 · AI

Avoiding (Heart) Failure: Physiologic-Based Targeting of the RAAS to Treat Subclinical HFpEF among PWH

$839,988
Suman Srinivasa · Massachusetts General Hospital · R01 · FY2021 · HL

Antigen-Specific NK Cell Memory Against SIV and HIV Vaccines

$839,952
Roger Keith Reeves · Beth Israel Deaconess Medical Center · R01 · FY2020 · AI

Improved delivery of bNAbs for targeting CNS infection in infants

$839,952
Jing Wen · University Of California Los Angeles · R01 · FY2025 · NS

Development of Broad-Spectrum Antiviral Agents

$839,875
Gary J Nabel · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

Single-Cell Analysis of the HIV/SIV Reservoir

$839,867
Dan H. Barouch · Beth Israel Deaconess Medical Center · R01 · FY2020 · AI

Adjuvants for Skin Immunization: Discovery and Mechanisms

$839,834
Ioanna Skountzou · Emory University · R01 · FY2017 · AI

Role of local antibodies in control of chronic genital herpes

$839,751
Anton M Sholukh · Fred Hutchinson Cancer Center · R01 · FY2025 · AI

Pharmacogenomics and Systems Pharmacology Approaches to Toxicity, Tolerability, and Comorbidities Associated with Modern Antiretroviral Therapies

$839,731
Inga Peter · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · HG

Escape of maternal plasma broadly neutralizing antibody as a mechanism of mother to child HIV transmission

$839,636
Sallie R. Permar · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · AI

Vaginal microbiota transplant to promote Lactobacillus-dominant cervicovaginal communities

$839,632
Caroline M Mitchell · Massachusetts General Hospital · R01 · FY2021 · AI

Identification of Novel Mucosal Immune Mechanisms Involved in Protection from HIV-1

$839,551
Jennifer M Lund · Fred Hutchinson Cancer Research Center · R01 · FY2020 · AI

Threshold of Cognitive Impairment after HIV Infection: Effect of Morphine

$839,533
David J Volsky · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · DA